COMMUNIQUÉS West-GlobeNewswire

Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
24/11/2025
Clinical validation successfully completed with Mayo Clinic Platform’s Validate program – marking the final clinical requirement prior to FDA 510(k) submission EchoSolv HF validation met the primary endpoint, delivering [...]
Curaechoice Selects CVS Caremark at its PBM
24/11/2025
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 Birmingham, Alabama, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Curaechoice, the nation’s #1 leader in No-Cost [...]
Providence Saint John’s Earns Magnet Recognition, The Gold Standard in Nursing Excellence
24/11/2025
SANTA MONICA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Providence Saint John’s Health Center has achieved Magnet ® recognition, the nation’s highest honor for nursing excellence, awarded by the American Nurses [...]
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
24/11/2025
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with [...]
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami
24/11/2025
Media Release COPENHAGEN, Denmark; November 24, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano will participate in a fireside chat at the Citi Global Healthcare [...]
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
24/11/2025
-- Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – --Cohort 7 Pharmacokinetic (PK) profile continues to demonstrate dose-proportionality and Cmax/Cmin ratio <2. Achieved [...]
Cannara Biotech réalise des revenus et une rentabilité records pour l’exercice 2025 et affiche pour la première fois un solde positif de bénéfices non répartis
24/11/2025
R ésultats financiers records pour l'exercice 2025 : total des produits, déduction faite des taxes et de 107,3 millions de dollars, BAIIA ajusté de 28,1 millions de dollars 1 , bénéfice net de 13,1 millions de dollars, [...]
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
24/11/2025
Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million 1 , net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million 1 [...]
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
24/11/2025
CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will participate in a fireside chat at the Piper [...]
Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR
24/11/2025
First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI’s registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, complementary [...]
Vaxil Announces Update on Non-Brokered Private Placement
24/11/2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (" Vaxil " or the " Company ") (TSX VENTURE: VXL) is pleased to announce that the Company, [...]
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
24/11/2025
WATERTOWN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Biomea Fusion to Participate at Upcoming Investor Conferences
24/11/2025
SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will [...]
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
24/11/2025
WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]
Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder
24/11/2025
Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026 More than 21 million US adults experience a major depressive episode each year CHATHAM, [...]
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
24/11/2025
Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on neflamapimod treatment for DLB New data demonstrating the utility of [...]
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
24/11/2025
DURHAM, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has completed its debt tender offer (the “Tender [...]
Tilray dévoile les produits de vapotage Good Supply au Québec avec l’introduction récente des produits de vapotage au Québec
24/11/2025
TORONTO, 24 nov. 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY), un leader mondial des biens de consommation, de l’industrie du cannabis, des boissons et du bien-être, annonce [...]
Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec
24/11/2025
TORONTO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and [...]

Pages